Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ISTA Pharmaceuticals
Irvine, California, United States
- Ownership
- Private
- Employees
- ~330
- Development stage
- Other
01
Overview
ISTA Pharmaceuticals was a leading US-based specialty pharmaceutical company focused on ophthalmology. It marketed several FDA-approved products for eye diseases including Bromday/Xibrom, Bepreve, Istalol, and Vitrase. At the time of its acquisition by Bausch + Lomb in June 2012 for $500 million, it was the third-largest branded prescription eye-care business in the US with an expanding portfolio targeting both approved indications and late-stage pipeline assets for dry eye, ocular inflammation/pain, and nasal allergies. The company had approximately $150 million in annual sales at acquisition[6][7].
- Therapeutic areas
- ImmunologyOphthalmology
- Modalities
- small moleculesenzyme injection
- Industry
- Biotech
02
Partnerships
No major external partnerships reported; close manufacturing relationship with Bausch + Lomb prior to acquisition
Beyond the preview
Go deeper on ISTA Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ISTA Pharmaceuticals.